The effect of garlic on fatigue and quality of life in MS patients

Evaluation of the garlic extract (Allium sativum) effect to improving fatigue and quality of life in patients with multiple sclerosis (MS) a randomized, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150721023282N15

Enrollment

Registered

2021-03-01

Start date

2020-11-29

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: Allium 400-mg tablets (manufactured by Amin company), every 12 hours, for 4 weeks. Intervention 2: Placebo group: Placebo tablets (manufactured by Amin company), ev

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Relapsing-remitting MS At least 6 months have passed since the diagnosis Complaints of obvious fatigue

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding Diseases causing fatigue acute recurrence stage

Design outcomes

Primary

Measure	Time frame
Fatigue severity. Timepoint: Before and after the intervention. Method of measurement: fatigue severity sacle (fss).;Quality of life. Timepoint: Before and after the intervention. Method of measurement: The Short Form Health Survey (SF-36).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Soltani

Esfahan University of Medical Sciences

soltani@pharm.mui.ac.ir+98 31 3786 5537

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026